铁塔等 发表于 2025-3-27 00:50:50
NanoScript: A Versatile Nanoparticle-Based Synthetic Transcription Factor for Innovative Gene Manipdescribe the construction of the NanoScript platform, which is designed with tunable properties to replicate the structure and function of TFs to bind to specific portions of the genome and regulate gene expression in a way that does not involve viral delivery.Aphorism 发表于 2025-3-27 03:11:36
Book 2017Latest editionscuss practical information on the synthesis and characterization of a variety of solution-phase and surface-bound nanomaterials, with examples of how they can be used in sensing, imaging, and therapeutics. Specific topics include the synthesis and characterization of molecule and biomolecule-functiCHASE 发表于 2025-3-27 08:01:38
http://reply.papertrans.cn/19/1881/188076/188076_33.png微粒 发表于 2025-3-27 09:30:11
http://reply.papertrans.cn/19/1881/188076/188076_34.png跟随 发表于 2025-3-27 16:56:46
http://reply.papertrans.cn/19/1881/188076/188076_35.pngflex336 发表于 2025-3-27 18:12:02
http://reply.papertrans.cn/19/1881/188076/188076_36.pngSOBER 发表于 2025-3-28 01:35:10
http://reply.papertrans.cn/19/1881/188076/188076_37.png一美元 发表于 2025-3-28 04:43:09
https://doi.org/10.1007/978-94-011-2406-5anowafers using polyvinyl alcohol and the instillation of a nanowafer on a mouse eye. The nanowafer, a small circular disk, is placed on the ocular surface, and it releases a drug as it slowly dissolves over time, thus increasing ocular bioavailability and enhancing efficiency to treat eye injuries.祸害隐伏 发表于 2025-3-28 07:20:30
Enzyme-Responsive Nanoparticles for the Treatment of Disease,d a new tissue targeting strategy where enhanced accumulation of nanomaterials occurs as a result of morphology changes to the material in response to overexpressed enzymes in diseased tissues. Herein, we describe the general strategy for the preparation of these enzyme-responsive nanoparticles (ER-NPs) for therapeutic applications.cinder 发表于 2025-3-28 13:16:21
Application of Hydrogel Template Strategy in Ocular Drug Delivery,anowafers using polyvinyl alcohol and the instillation of a nanowafer on a mouse eye. The nanowafer, a small circular disk, is placed on the ocular surface, and it releases a drug as it slowly dissolves over time, thus increasing ocular bioavailability and enhancing efficiency to treat eye injuries.